Freedom Capital Markets Starts AtriCure (ATRC) at Buy

April 1, 2026 7:21 AM EDT Send to a Friend
Freedom Capital Markets analyst Keith Hinton initiates coverage on Articure (NASDAQ: ARTC) with a Buy rating and a price target ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login